Changer de langue :      

Exposants confirmés :

Partenaires presse officiels :







> Programme avec les orateurs confirmés sur IMPLANTS 2010

Le programme élaboré pour la conférence 2010 comprendra environ 30 personnalités internationales les plus représentatives de l'industrie des implants. Tout en abordant les aspects les plus larges possibles du marché des implants orthopédiques en Europe, IMPLANTS 2010 mettra également en vedette des noms importants du marché américain et des marchés émergents d'Asie.

Survolez la photo pour lire la biographie.

Implants 2010 - Program of the 6th edition

Day 1 - May the 27th:

9:30 - 11:35

Slot 1
Chairman: Ali MADANI, General Manager, AVICENNE DEVELOPPEMENT

Market Strategy and Contract manufacturing issues

Ali MADANI


General Manager,
AVICENNE DEVELOPPEMENT

Worldwide Orthopaedic Market and Contract manufacturing strategy

- Hip, Knee, Spine Trauma, Orthobiologics and dental Implants markets and trends
- Contract manufacturing market Vs In house manufacturing
- The Major and Challenger strategies
- Risks and Limits

Simon ADAM


Supplier Quality Risk Management Director,
DEPUY IRELAND

The changing regulatory landscape and implications for medical device manufacturers

Jean-Louis COLDERS


Chief Executive Officer,
LISI AEROSPACE

Building a leading edge worldclass medical contractor

- Build up process
- Outstanding points

Michael RUENZ


President,
ATS STELLITE SAS & SFERIC STELLITE SAS

Helping the development of our customers in the light of the globalisation of orthopaedic markets. A new challenge for contract manufacturers!



11:35 - 14:00

Networking lunch


14:00 - 16:05

Slot 2
Chairman: Daniel DELFOSSE, Vice President Innovation & Technology, MATHYS

Innovation in Products and Materials and Tribology

Azad HUSSAIN


Test Engineer, Implant Development Centre,
SMITH & NEPHEW ORTHOPAEDICS

Technical factors from the largest MoM retrieval database globally

- Implant failure mechanisms
- Mal-orientation
- Edge loading

Dr Robert M. STREICHER


Director of Strategic Research,
STRYKER

The Potential of Nanotechnology in Orthopaedics

- Nanotechnology enhanced implant surfaces modify the cellular and bacterial reaction and enhance osseointegration as well as preventing infection
- Nanoparticles and Carbon Nanotubes have been shown to enhance the mechanical resistance of most biomaterials
- Nanotechnology is an expanding opportunity for the orthopaedic industry to enhance existing implant’s performance and also allows for new applications

Daniel DELFOSSE


Director Innovation & Technology,
MATHYS

First clinical results with vitamin-doped cross-linked polyethylene

- Hype or hope for vitamin-doped polyethylene?
- Improved wear and longterm stability
- Innovation based on material development

Ralf KLABUNDE


Director, Tribology and Polymer Research,
ZIMMER GmbH

Biomaterials in interaction with Cartilage

- Proposition for cartilage friendly biomaterials
- Assessment of cartilage friendliness
- Presentation of results

Zhongmin JIN


Professor of Computational Bioengineering, Institute of Medical and Biological Engineering, School of Mechanical Engineering,
UNIVERSITY OF LEEDS

Tribology of Different Bearings for Artificial Hip Joints

- Importance of tribology
- Advantages and disadvantages of different bearings
- Future developments

16:05 - 16:50

Networking coffee break


16:50 - 18:30

Two Parallel Slots


Slot 3
Chairman: Bernard MASSON, Special Advisor, CERAMTEC MEDICAL PRODUCTS

Raw Materials and Ceramics

Jean-Paul DICHTEL

&
Jean-Marc LARDON


Technical Manager,
STAINLESS


&


Application Engineer,
AUBERT & DUVAL

Corrosion: still an issue?

- Recent improvements have been made in the field of stainless steels which offer tremendous properties.
- Examples of X15TN, used today for drills, cutting tools… and MX466 a precipitation hardening grade capable of very high strength combined with good toughness will be given

Marcus JARMAN-SMITH


Technology Leader,
INVIBIO Ltd

Understanding implantable grade PEEK’s interface and interaction with cells

- Increasing use of PEEK biomaterial (over 2.5m devices) in contact with tissue
- Tailoring the tissue response may be achieved through modifying versatile PEEK through addition of compounds (eg. HA) or surface modifications
- Discussing this growing interest areas and examining some examples that interact or interface with human and bacterial cells.

Wolfhart RIEGER


Member of the board,
METOXIT AG

Ceramics in Implantology: History and Future

- Load bearing ceramics
- Implantology in orthopaedics and dental
- Restaurative application of bioceramics

Bernard MASSON


Special Advisor,
CERAMTEC MEDICAL PRODUCTS

Evolution of ceramics in Orthopaedics

- The main technological stages
- Worldwide ceramics market trends
- Future applications

Slot 4
Chairman: Ali MADANI, General Manager, AVICENNE DEVELOPPEMENT

Coating

Sébastien BEAUVAIS


Technical Director,
TEROLAB SURFACE

Design requirements for coated implants

Francesco BUCCIOTTI


Research & Development,
EUROCOATING S.P.A.

Innovation in Biomedical Coatings

- Advanced Sponge Plasma Spray Coating to enhance the bone ingrowth
- Coatings development for innovative substrates
- Eurocoating management of Plasma Spray and other innovative technologies (e.g. Rapid Manufacturing) with a "customer-oriented" philosophy to support our customer products development

Armando SALITO


Head of Technology,
ALHENIA AG

The coated implants of the future are ready now

- Overview of the medical coating industry evolution
- New generation of tough ceramic coatings
- VPS coatings on PEEK substrates
- Multifunctional bio-resorbable coatings with biofilm inhibition and optimal implant fixation

18:30 - 20:00

Cocktail on Exhibition Hall



Day 2 - May the 28th:

9:00 - 10:40

Two Parallel Slots


Slot 5
Chairman: Tim LAWTON, Director, C-REG MEDICAL

Regulatory, Certification and Pricing issues

Laure LE CALVÉ


Avocat au Barreau de Paris,
BESLAY + LE CALVÉ AARPI

Update on French legislation on medical devices

- Modification on the law relating to clinical trials,
- Legal consequences of the Directive 2007/47,
- Reimbursement of medical devices (T2A / LPP / GHS),
- Product liability recent case-laws

Dario PIROVANO


Consultant Regulatory Affairs,
EUCOMED

Will the changes introduced by 2007/47 and the new allocation of medical devices to the Directorate General Health and Consumer protection affect this sector?

- Regulatory developments at European level: the recast
- Advanced therapies and combination products
- Revision surgery

Tim LAWTON


Director,
C-REG MEDICAL Sarl

FDA, is it worth it to make the effort

- Changing face of the FDA, how does it effect an European PME
- The FDA submission is one thing, but what about the rest?
- As an European manufacturer, should we still keep control of the FDA
submission?

Marco BAFAN


Sr. Research Analyst - Medical Devices,
Biomedical Engineering M.Sc,
Southern California
NERAC Inc

Obtaining Medical Device Reimbursement Within the United States

- The role of the Food and Drug Administration (FDA) in device approval
- Understanding the Centers for Medicare and Medicaid (CMS) and how this affects reimbursement
- Developing a strategy for reimbursement, considering national versus regional approaches and private insurers

Slot 6
Chairman: François ORY, President, FORECREU BIOMETAL

Processing, Finishing, Marking & Cleaning

François ORY


President,
FORECREU BIOMETAL

Processing cannulated bars for trauma applications

- Processing stainless and titanium into cannulated bars
- Improved features and properties
- Time to market and economics from the customer point of view


Rüdiger BÖHM


Authorized Manager - Manager of Test Lab,
RÔSLER OBERFLÄCHENTECHNIK GmbH

Process Innovation in Vibratory Finishing of implants - Drag Grinding Techniques for high ambitious surfaces

- Machine Systems
- Process Technology
- Environmental Aspects


Pascal SENENTZ


General Manager,
NGL CLEANING TECHNOLOGY SA

High Precision Cleaning Processes

- Cleaning and surface preparation
- Approve processes
- Wastewater treatment


Antoine ALVES


Pathologist,
BIOMATECH - a Namsa Company

Advanced histopathology for bone implants

- Tissular exploration of the performance of bone implant needs adequate tools
- Beside ISO standards, proposition of innovative approaches to add value to the outcome of your products is discussed

10:40 - 11:10

Networking coffee break


11:10 - 12:30

Slot 7
Chairman: Thomas NYDEGGER, Manager Spine Research EMEA, ZIMMER GmbH

Spine, Trauma and Orthobiologics

Bruce DE LA GRANGE

President & CEO,
VEXIM

The SpineJack® Implant: An innovation in treating Vertebral Compression Fractures

- About the Implant
- Clinical Tests and Results
- About VEXIM, SAS

Thomas NYDEGGER


Manager Spine Research EMEA,
ZIMMER GmbH

Introduction to dynamic stabilization of the spine

- The function of the components of a dynamic stabilization device for the spine
- Materials used and their properties
- Long term bio-stability of the used polymers

Jasper VAN DE SANDE


Manager Business Development & Business Intelligence,
MEDTRONIC SPINAL & BIOLOGICS ECA

Postition of Orthobiologics in Spine for Western Europe

- Current positioning of orthobiologics
- Classifications and trends
- Drug & device combinations in Spine
- Future market for othobiologics

12:30 - 14:15

Networking lunch


14:15 - 15:30

Slot 8
Chairman: Christophe PILLOT, Senior Consultant, AVICENNE DEVELOPPEMENT

Manufacturing Implants and Surgical Instrumentation

Anthony GUITTEREZ


Market Manager,
CARPENTER TECHNOLOGY

Considerations to becoming a true global material supplier to the orthopedic market

- What are they key areas of focus for today’s OEMs and CMs?
- What are they key areas of focus for today’s raw material suppliers?
- How do we merge these needs to develop successful long-term products?

Claude RAUSCHER


CEO,
AESCULAP SAS

Automated polishing of the femurs

- Presentation of the company AESCULAP SAS Chaumont: history & key figures
- Description of the automated polishing process
- Performance (Quantity per day, alteration rate)

Grégoire PONCHON


Commercial Engineer,
ORIGIN3D

Existing solutions for Single use medical devices in thermoplastics

- Status of our Hip Rasps.
- Advantage and inconvenience
- Development in progress and future application

Christophe PILLOT


Senior Consultant,
AVICENNE DEVELOPPEMENT

Manufacturing Implants, Instruments, cases, others where is the cash cow?

- Orthopaedic supply chain trends
- Success key for contract manufacturers?
- Contract manufacturing risks & limits
- Prospective, main challenge for 2020


> Qui sont les orateurs :

Les hauts responsables des fabricants d'orthopédie et les principaux acteurs de l'industrie des implants sont conviés à venir parler sur Implants. Notamment, ils sont : reponsables chargés des opérations, directeurs généraux, représentants des organismes européens de réglementation, chercheurs, gestionnaires de production, chirurgiens, directeurs de développement des affaires, directeurs achats, directeurs marketing , des représentants du ministère de la santé de différents pays européens, les entreprises manufacturières et les sous-traitants, R & D, etc.


> Statistique des visiteurs 2009 :

159 délégués ont assisté à la conférence et visité l'exposition :
60 % de FRANCE, 30 % du reste de l'Europe et 10 % du reste du monde.

403 visiteurs ont visité seulement l'exposition :
70 % de FRANCE, 23 % du reste de l'Europe et 7 % du reste du monde.
Reste de l'Europe : 43 % d'Allemagne et de la Suisse, 25 % du Royaume-Uni et de l'Irlande, 32 % du reste de l'EUROPE.


> Profil des visiteurs :

Les visiteurs sur IMPLANTS sont des acheteurs ou responsables de socétés orthopédiques, des fabricants ou sous-traitants d'implants :

    - Chief Executive Officers
    - Chief Financial Officers
    - Chief Operations Officers
    - Managing Directors
    - Sales managers
    - Marketing Directors
    - Production Managers
    - Purchasing Directors
    - Export Directors
    - Development Managers Knee
    - Development Managers Hip
    - Development managers Spine
    - R&D managers
    - Director Strategic sourcing
    - Product managers Knee
    - Product managers Hip
    - Product Managers Spine
    - Business Developpement Directors
    - Business Intelligence

Lyon, l' "Implants Valley“ française, à proximité immédiate de l'Italie, la Suisse et l'Allemagne :


> Les sociétés qui ont participé aux éditions précédentes (2005-2009) :

Depuis sa création, la conférence IMPLANTS réunit les grands noms des entreprises manufacturières et sous-traitantes d'implants orthopédiques.

> Téléchargez la liste (pdf)




Pour toute information, envoyez-nous vos coordonnées par E-Mail ou appelez-nous au +33 247 273 330.